Apollomics APLM
NASDAQ APLM
$21.59 -0.46 (-2.07%)
As of: Oct 21, 2026 · 11:28 AM EDT

Apollomics (APLM) Notes Payables (2023 - 2024)

Updated

Apollomics' Notes Payables came in at $3.51 million for Q2 2024.

Analysis

Apollomics (APLM) Notes Payables (2023 - 2024) Analysis & Trends

At the end of FY2023, Apollomics' Notes Payables was $4.24 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Apollomics 31.22 Mn -9.87 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 3.51 Mn
Dec 31, 2023 4.24 Mn
API Access

Apollomics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=APLM&period=max&api_key=YOUR_API_KEY